Viewing on a PDA? Click here to view this email in text.
If you cannot view this email properly please click here.

 

header_pharma.jpg logo_ssb.jpg
  Save the Date | Goettingen, May 24-25
  How to overcome new challenges in Downstream Processing?  
   
 
 


SAVE THE DATE - May 24 - 25, 2011
Join the 7th European Downstream Technology Forum

Sartorius College, Goettingen, Germany
 
 
Based upon a series of successful meetings since 2004, the Downstream Forum provides the latest technical and scientifical approaches in downstream processing to accelerate development and optimize production of vaccines and biopharmaceuticals.
 
The downstream processing has seen many challenges over the past few years; from handling high product titres into the so called “purification bottleneck” to running single-use platforms. The recent surge in single-use technologies has helped reduce personnel, validation costs and risk to product safety, as well as reducing time to market.
 
This event is an interactive forum for biotech industry experts to specifically address the current needs and innovations in purification technologies. We cordially invite you to our European Downstream Technology Forum on May 24 – 25, 2011, in Goettingen, Germany.
 
Please find the registration form and other details of the forum on:
www.sartorius-stedim.com/downstream
 
We look forward to welcoming you to the event.
 
 ArrowConference Webpage 
 
 
  Highlights from the Agenda
 
 


 

Viral vaccine processes: Towards intensification and quality
Marcel de Vocht, Downstream Processing Manager, Crucell, Netherlands
 
Development of a simple and efficient monoclonal antibodies polishing platform to replace the traditional anion exchange chromatography or membrane adsorber using Sartobind STIC
Yun (Kenneth) Kang, Ph.D., Senior Scientist, Head of Purification Team Bioprocess Sciences ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, New York, USA
 
How to shorten downstream processing for monoclonal antibodies
Laure Landric Burtin, Process Development, Purification Manager Sanofi Aventis, France
 
Designing a single-use approach for harvest clarification
Christian Skjødt, MSc Scientist,Cell Culture Manufacturing, CMC Biologics, Denmark
 
Leveraging innovation for more efficient downstream development and manufacturing
Jens H. Vogel, Director, Isolation & Purification & Global CMC Dev. Team Leader,Global Biological Development,Bayer Healthcare, USA
 
Improving viral spike purity for parvoviruses and performance at filtration process steps
Joseph Hughes, Vice President of Biologics Testing Services, Wuxi AppTec Inc., USA
 
 
For the complete agenda and other details please follow the link:
 
 
 Arrowwww.sartorius-stedim.com/downstream 
 
 
  Imprint  
  Published by
Sartorius Stedim Biotech GmbH
August Spindler Strasse 11
D-37079 Goettingen, Germany

Phone +49.551.308.0
Fax +49.551.308.3289
newsletter@sartorius.com
www.sartorius-stedim.com		   Executive Board
Volker Niebel, Dr. Oscar-Werner Reif, Reinhard Vogt

Chairman of the Supervisory Board
Prof. Dr. Dres. h.c. Arnold Picot, Gauting		   Local Court of Registration
Amtsgericht Göttingen
HRB-Nr. 200266		  
 
Don’t want to receive this version of the newsletter anymore? You can unsubscribe here.
If you don’t want to receive any more information from Sartorius via the newsletter in general, please click here.
  

A PRODUCT
ANNOUNCEMENT FROM:
  
BP logo